FAQ/Help |
Calendar |
Search |
Today's Posts |
03-02-2012, 07:45 AM | #1 | |||
|
||||
Member
|
http://medicalxpress.com/news/2012-0...se-animal.html
...UCLA professor of neurology Jeff Bronstein and UCLA associate professor of neurology Gal Bitan, along with their colleagues, report the development of a novel compound known as a "molecular tweezer," which in a living animal model blocked α-synuclein aggregates from forming, stopped the aggregates' toxicity and, further, reversed aggregates in the brain that had already formed. And the tweezers accomplished this without interfering with normal brain function. The research appears in the current online edition of the journal Neurotherapeutics...
__________________
Sim00 Born in 1969, diagnosed PD in 2007, first symptoms 2004. DBS in July 2016. |
|||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
Stem cells reverse disease in a model of Parkinson's disease | Parkinson's Disease | |||
Conditional Model of Parkinson's Disease Developed | Parkinson's Disease | |||
VP025 Provides a Neuroprotective Effect in Preclinical Model of Parkinson's Disease | Parkinson's Disease | |||
GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease. | Parkinson's Disease | |||
DDD mice, a novel acute mouse model of Parkinson's disease | Parkinson's Disease |